专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2013100298A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION 审中-公开
标题翻译：正性感光树脂组合物
公开(公告)号：WO2013100298A1
公开(公告)日：2013-07-04
申请号：PCT/KR2012/005691
申请日：2012-07-17
申请人： CHEIL INDUSTRIES INC. , KWON, Ji-Yun , LEE, Jong-Hwa , CHO, Hyun-Yong , KIM, Dae-Yun , KIM, Sang-Kyeon , KIM, Sang-Kyun , KIM, Sang-Soo , YOON, Eun-Kyung , LEE, Jun-Ho , LEE, Jin-Young , CHEON, Hwan-Sung , HONG, Chung-Beom , HWANG, Eun-Ha
发明人： KWON, Ji-Yun , LEE, Jong-Hwa , CHO, Hyun-Yong , KIM, Dae-Yun , KIM, Sang-Kyeon , KIM, Sang-Kyun , KIM, Sang-Soo , YOON, Eun-Kyung , LEE, Jun-Ho , LEE, Jin-Young , CHEON, Hwan-Sung , HONG, Chung-Beom , HWANG, Eun-Ha
IPC分类号： G03F7/022 , G03F7/004 , G02F1/13
CPC分类号： G03C1/61 , G03F7/0226 , G03F7/0233 , G03F7/0751 , G03F7/105
摘要： Disclosed is a positive photosensitive resin composition that includes (A) an alkali soluble resin selected from a polybenzoxazole precursor, a polyimide precursor, and a combination thereof, (B) a photosensitive diazoquinone compound, (C) a phenol compound, (D) an organic dye and (E) a solvent, wherein the organic dye (D) includes at least one red dye having an absorption wavelength of 590 to 700 nm, at least one yellow dye having an absorption wavelength of 550 to 590 nm, and at least one blue dye having an absorption wavelength of 450 to 500 nm.
摘要翻译：公开了一种正型感光性树脂组合物，其包含（A）选自聚苯并恶唑前体，聚酰亚胺前体及其组合的碱溶性树脂，（B）感光性重氮醌化合物，（C）酚化合物，（D）有机染料和（E）溶剂，其中有机染料（D）包括至少一种吸收波长为590-700nm的红色染料，至少一种吸收波长为550至590nm的黄色染料，至少一种蓝色染料，其吸收波长为450〜500nm。

2. 发明申请

WO2010041837A2 A USE OF THE LIQUIRITIGENIN ABUNDANT EXTRACT OR LIQUIRITIGENIN DERIVED THEREFROM FOR INCREASING BILE FLOW, CHOLERETIC EFFECT, AND FOR PREVENTING AND TREATING CHOLESTATIC LIVER DISEASES 审中-公开
标题翻译：使用液态碘甘油富含提取物或源于此的提取液以增加胆汁流动，促进胆碱性效应以及预防和治疗胆汁淤积性肝病
公开(公告)号：WO2010041837A2
公开(公告)日：2010-04-15
申请号：PCT/KR2009/005451
申请日：2009-09-24
申请人： SNU R&DB FOUNDATION , KIM, Sang Geon , KIM, Sang Chan , KIM, Young Woo
发明人： KIM, Sang Geon , KIM, Sang Chan , KIM, Young Woo
IPC分类号： A61K36/484
CPC分类号： A61K36/484
摘要： The present invention is related to a composition comprising an extract of licorice or liquiritigenin derived therefrom, which significantly increases bile flow rate and biliary excretion of bile acid, GSH and bilirubin. Consistent with these results, the inventive composition comprising an extract of licorice or liquiritigenin derived therefrom decrease the blood chemical markers including ALT as a hepatoprotective marker, and ALP and γ-GTP, as cholestatasis markers, and histochemical markers including central necrosis and inflammation in galactosamine/lipopolysaccharide-induced hepato-toxicity animal model when the inventive extract or compound of the present invention was orally and intravenously administrated thereto.
摘要翻译：本发明涉及包含由其衍生的甘草或甘草提取物的组合物，其显着增加胆汁酸流速和胆汁酸，GSH和胆红素的胆汁排泄。与这些结果一致，包含由其衍生的甘草或甘草甜素提取物的本发明组合物降低血液化学标记，包括作为肝保护性标记的ALT和作为胆汁淤积标记的ALP和γ-GTP，以及包括中央坏死和半乳糖胺炎症的组织化学标记 /脂多糖诱导的肝毒性动物模型，当将本发明的本发明提取物或化合物口服和静脉内施用于其上时。

3. 发明申请

WO2004063661A1 APPARATUS AND METHOD FOR MEASUREMENT OF FILM THICKNESS USING IMPROVED FAST FOURIER TRANSFORMATION 审中-公开
标题翻译：使用改进的快速傅里叶变换测量薄膜厚度的装置和方法
公开(公告)号：WO2004063661A1
公开(公告)日：2004-07-29
申请号：PCT/KR2003/001203
申请日：2003-06-18
申请人： ELLIPSO TECHNOLOGY CO., LTD. , KIM, Sang-Youl , KIM, Sang-Jun
发明人： KIM, Sang-Youl , KIM, Sang-Jun
IPC分类号： G01B7/02
CPC分类号： G01B11/0625
摘要： The present invention relates to an apparatus and method for a measurement of a film thickness using an improved fast Fourier transformation. The apparatus includes a light source, a light receiving unit for converging a light from the light source, a detection unit for splitting a reflection light reflected by the surface of the sample and inputted into the optical fabric through the lens, and outputted to the other side of the optical fabric based on a light intensity of each wavelength and providing a certain amount of wavelength, a conversion unit for converting a wavelength based spectrum data detected by the detection unit into an analog signal and then converting into a digital signal through a converter, a computation unit for computing the number of vibrations based on a high speed Fourier transformation, and an analyzing unit for measuring a film thickness.
摘要翻译：本发明涉及使用改进的快速傅里叶变换来测量膜厚度的装置和方法。该装置包括光源，用于会聚来自光源的光的光接收单元，用于将由样品表面反射的反射光分离并通过透镜输入到光学织物中的检测单元，并输出到另一个基于每个波长的光强度并提供一定量的波长的转换单元，用于将由检测单元检测到的基于波长的频谱数据转换为模拟信号，然后通过转换器转换成数字信号的转换单元，用于计算基于高速傅里叶变换的振动次数的计算单元和用于测量膜厚度的分析单元。

4. 发明申请

WO2011034362A3 COMPOSITION CONTAINING SAURURUS CHINENSIS EXTRACT OR SAUCHINONE AS AN ACTIVE INGREDIENT, FOR PREVENTING AND TREATING DISEASES CAUSED BY THE OVEREXPRESSION OF LXR-? 审中-公开
标题翻译：含有SAURURUS CHINENSIS EXTRACT或SAUCHINONE作为活性成分的组合物，用于预防和治疗由LXR-过表达引起的疾病
公开(公告)号：WO2011034362A3
公开(公告)日：2011-09-01
申请号：PCT/KR2010006365
申请日：2010-09-16
申请人： SNU R&DB FOUNDATION , KIM SANG GEON , KIM SANG CHAN , KIM YOUNG CHOONG , KIM YOUNG WOO
发明人： KIM SANG GEON , KIM SANG CHAN , KIM YOUNG CHOONG , KIM YOUNG WOO
IPC分类号： A61K31/36 , A23L1/30 , A61K36/78 , A61P1/16
CPC分类号： A61K36/78 , A23L33/105
摘要： The present invention relates to a composition containing Saururus chinensis extract or Sauchinone as an active ingredient, which inhibits the expression or activity of liver X receptor a (LXRa) or sterol response element binding protein-1 (SREBP-1), and which can thus be used in preventing, improving, and treating diseases caused by the overexpression or activity of LXRa or SREBP-1. The composition of the present invention exhibits remarkable effects of inhibiting adipogenic gene expression, and further inhibiting the accumulation of triglycerides in liver tissue, and therefore is advantageous in treating fatty liver caused by metabolic disorders resulting from a high-fat diet. In addition, the composition of the present invention can be effectively used in preventing, improving, and treating, for example, liver diseases such as fatty liver caused by the accumulation of liver lipids, hypertriglyceridemia, hyperreninemia, renin-induced hypertension, aldosteronism, adrenoleukodystrophy, glomerulosclerosis, proteinuria, renal failure, etc.
摘要翻译：本发明涉及含有Saururus chinensis提取物或Sauchinone作为活性成分的组合物，其抑制肝X受体a（LXRa）或固醇反应元件结合蛋白-1（SREBP-1）的表达或活性，因此可以用于预防，改善和治疗由LXRa或SREBP-1的过表达或活性引起的疾病。本发明的组合物显示出显着的抑制脂肪形成基因表达的效果，进一步抑制甘油三酯在肝组织中的积聚，因此有利于治疗由高脂肪饮食引起的代谢紊乱引起的脂肪肝。此外，本发明的组合物可以有效地用于预防，改善和治疗例如由肝脂肪积聚引起的肝脏疾病，高甘油三酯血症，高肾血
氨酸血症，肾素性高血压，醛固酮增多症，肾上腺脑白质营养不良，肾小球硬化，蛋白尿，肾衰竭等

5. 发明申请

WO2010041837A3 A USE OF THE LIQUIRITIGENIN ABUNDANT EXTRACT OR LIQUIRITIGENIN DERIVED THEREFROM FOR INCREASING BILE FLOW, CHOLERETIC EFFECT, AND FOR PREVENTING AND TREATING CHOLESTATIC LIVER DISEASES 审中-公开
标题翻译：使用衍生物提取物或其衍生物用于增加胆汁流动，舒适作用和预防和治疗胆汁淤积性疾病的方法
公开(公告)号：WO2010041837A3
公开(公告)日：2010-08-12
申请号：PCT/KR2009005451
申请日：2009-09-24
申请人： SNU R&DB FOUNDATION , KIM SANG GEON , KIM SANG CHAN , KIM YOUNG WOO
发明人： KIM SANG GEON , KIM SANG CHAN , KIM YOUNG WOO
IPC分类号： A61K36/484
CPC分类号： A61K36/484
摘要： The present invention is related to a composition comprising an extract of licorice or liquiritigenin derived therefrom, which significantly increases bile flow rate and biliary excretion of bile acid, GSH and bilirubin. Consistent with these results, the inventive composition comprising an extract of licorice or liquiritigenin derived therefrom decrease the blood chemical markers including ALT as a hepatoprotective marker, and ALP and ?-GTP, as cholestatasis markers, and histochemical markers including central necrosis and inflammation in galactosamine/lipopolysaccharide-induced hepato-toxicity animal model when the inventive extract or compound of the present invention was orally and intravenously administrated thereto.
摘要翻译：本发明涉及包含由其衍生的甘草或甘草素的提取物的组合物，其显着增加胆汁流动速率和胆汁酸，GSH和胆红素的胆汁排泄。与这些结果一致，包含甘草或甘草素衍生物的提取物的本发明组合物降低血液化学标志物，包括ALT作为肝保护标记，ALP和β-GTP作为胆汁淤积标志物，组织化学标志物包括半乳糖胺中的中枢坏死和炎症 /本发明的本发明的提取物或化合物经口和静脉内给药时的/脂多糖诱导的肝毒性动物模型。

6. 发明申请

WO2011102695A3 COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY OVER-EXPRESSION OF LXR?, CONTAINING LIQUIRITIGENIN OR ISOLIQUIRITIGENIN AS ACTIVE INGREDIENT 审中-公开
标题翻译：用于预防或治疗由LXRβ过度表达引起的疾病的组合物，含有作为活性成分的液体或间苯二酚
公开(公告)号：WO2011102695A3
公开(公告)日：2012-02-02
申请号：PCT/KR2011001150
申请日：2011-02-22
申请人： SNU R&DB FOUNDATION , KIM SANG GEON , KIM SANG CHAN , KIM YOUNG WOO
发明人： KIM SANG GEON , KIM SANG CHAN , KIM YOUNG WOO
IPC分类号： A61K31/352 , A61K31/12 , A61K36/484 , A61P9/12
CPC分类号： A61K36/484 , A61K31/12
摘要： The present invention relates to a composition for preventing, relieving and treating diseases caused by expression or over-activation of liver X receptor a (LXRa) or sterol response element binding protein-1 (SREBP-1), containing liquiritigenin, isoliquiritigenin or a Glycyrrhizae Radix processed fraction extract containing the same as an active ingredient. The composition of the present invention can be effectively used to prevent, relieve and treat diseases such as fatty liver, hypertriglyceridemia, hyperreninemia, renin-induced hypertension, aldosteronism, adrenoleukodystrophy, glomerulosclerosis, proteinuria, renal failure, and the like. In addition, the composition of the present invention can be used to prevent and treat obesity.
摘要翻译：本发明涉及用于预防，缓解和治疗由含有甘草素，异iqu草素或甘草的肝X受体a（LXRa）或固醇应答元件结合蛋白-1（SREBP-1）的表达或过度活化引起的疾病的组合物含有与活性成分相同的甘草加工级分提取物。本发明的组合物可以有效地用于预防，缓解和治疗脂肪肝，高甘油三酯血症，高肾血
氨酸血症，肾素性高血压，醛固酮增多症，肾上腺脑白质营养不良，肾小球硬化，蛋白尿，肾功能衰竭等疾病。此外，本发明的组合物可用于预防和治疗肥胖症。

7. 发明申请

WO2011102695A2 COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY OVER-EXPRESSION OF LXR?, CONTAINING LIQUIRITIGENIN OR ISOLIQUIRITIGENIN AS ACTIVE INGREDIENT 审中-公开
标题翻译：用于预防或治疗由LXRβ过度表达引起的疾病的组合物，含有作为活性成分的液体或间苯二酚
公开(公告)号：WO2011102695A2
公开(公告)日：2011-08-25
申请号：PCT/KR2011001150
申请日：2011-02-22
申请人： SNU R&DB FOUNDATION , KIM SANG GEON , KIM SANG CHAN , KIM YOUNG WOO
发明人： KIM SANG GEON , KIM SANG CHAN , KIM YOUNG WOO
IPC分类号： A61K31/352 , A61K31/12 , A61K36/484 , A61P9/12
CPC分类号： A61K36/484 , A61K31/12
摘要： The present invention relates to a composition for preventing, relieving and treating diseases caused by expression or over-activation of liver X receptor a (LXRa) or sterol response element binding protein-1 (SREBP-1), containing liquiritigenin, isoliquiritigenin or a Glycyrrhizae Radix processed fraction extract containing the same as an active ingredient. The composition of the present invention can be effectively used to prevent, relieve and treat diseases such as fatty liver, hypertriglyceridemia, hyperreninemia, renin-induced hypertension, aldosteronism, adrenoleukodystrophy, glomerulosclerosis, proteinuria, renal failure, and the like. In addition, the composition of the present invention can be used to prevent and treat obesity.
摘要翻译：本发明涉及用于预防，缓解和治疗由含有甘草素，异iqu草素或甘草的肝X受体a（LXRa）或固醇应答元件结合蛋白-1（SREBP-1）的表达或过度活化引起的疾病的组合物含有与活性成分相同的甘草加工级分提取物。本发明的组合物可以有效地用于预防，缓解和治疗脂肪肝，高甘油三酯血症，高肾血
氨酸血症，肾素性高血压，醛固酮增多症，肾上腺脑白质营养不良，肾小球硬化，蛋白尿，肾功能衰竭等疾病。此外，本发明的组合物可用于预防和治疗肥胖症。

8. 发明申请

WO2011034362A9 COMPOSITION CONTAINING SAURURUS CHINENSIS EXTRACT OR SAUCHINONE AS AN ACTIVE INGREDIENT, FOR PREVENTING AND TREATING DISEASES CAUSED BY THE OVEREXPRESSION OF LXR-? 审中-公开
标题翻译：含有苏云金芽胞杆菌提取物或SAUCHINONE作为活性成分的组合物，用于预防和治疗由过度表达LXR-引起的疾病。
公开(公告)号：WO2011034362A9
公开(公告)日：2011-06-30
申请号：PCT/KR2010006365
申请日：2010-09-16
申请人： SNU R&DB FOUNDATION , KIM SANG GEON , KIM SANG CHAN , KIM YOUNG CHOONG , KIM YOUNG WOO
发明人： KIM SANG GEON , KIM SANG CHAN , KIM YOUNG CHOONG , KIM YOUNG WOO
IPC分类号： A61K31/36 , A23L1/30 , A61K36/78 , A61P1/16
CPC分类号： A61K36/78 , A23L33/105
摘要： The present invention relates to a composition containing Saururus chinensis extract or Sauchinone as an active ingredient, which inhibits the expression or activity of liver X receptor a (LXRa) or sterol response element binding protein-1 (SREBP-1), and which can thus be used in preventing, improving, and treating diseases caused by the overexpression or activity of LXRa or SREBP-1. The composition of the present invention exhibits remarkable effects of inhibiting adipogenic gene expression, and further inhibiting the accumulation of triglycerides in liver tissue, and therefore is advantageous in treating fatty liver caused by metabolic disorders resulting from a high-fat diet. In addition, the composition of the present invention can be effectively used in preventing, improving, and treating, for example, liver diseases such as fatty liver caused by the accumulation of liver lipids, hypertriglyceridemia, hyperreninemia, renin-induced hypertension, aldosteronism, adrenoleukodystrophy, glomerulosclerosis, proteinuria, renal failure, etc.
摘要翻译：本发明涉及含有Saururus chinensis提取物或Sauchinone作为活性成分的组合物，其抑制肝X受体α（LXRα）或甾醇应答元件结合蛋白-1（SREBP-1）的表达或活性，并且因此可以用于预防，改善和治疗由LXRα或SREBP-1的过表达或活性引起的疾病。本发明的组合物显示出显着的抑制脂肪形成基因表达的效果，并进一步抑制甘油三酯在肝组织中的积聚，因此有利于治疗由高脂饮食引起的代谢紊乱引起的脂肪肝。另外，本发明的组合物可有效用于预防，改善和治疗例如由肝脏积聚引起的脂肪肝，高甘油三酯血症，高血压，肾素诱导性高血压，醛固酮增多症，肾上腺脑白质营养不良，肾小球硬化，蛋白尿，肾功能衰竭等。

9. 发明申请

WO2009031802A3 NANOSTRUCTURE COMPOSITE AND METHOD OF PRODUCING THE SAME 审中-公开
标题翻译：纳米结构复合材料及其制造方法
公开(公告)号：WO2009031802A3
公开(公告)日：2009-04-23
申请号：PCT/KR2008005165
申请日：2008-09-03
申请人： KOREA ELECTRONICS TELECOMM , KUMOH NAT INST TECHNOLOGY , KIM SANG-HYEOB , PARK SEUNG-SIK , KIM SANG-WOO , LEE GONG-GU , KIM SUNG-JIN , MAENG SUNGLYUL , LEE SUNYOUNG , MYOUNG HEY-JIN
发明人： KIM SANG-HYEOB , PARK SEUNG-SIK , KIM SANG-WOO , LEE GONG-GU , KIM SUNG-JIN , MAENG SUNGLYUL , LEE SUNYOUNG , MYOUNG HEY-JIN
IPC分类号： B82B3/00
CPC分类号： H01J9/025 , H01J1/304 , H01J2201/30469 , H01J2329/0455 , Y10T428/24355
摘要： Provided is a nano structure composite and a method of manufacturing the same. More specifically, a nano structure composite that includes a substrate, a first layer formed of carbon nano structures on the substrate, and a second layer formed of metal oxide nano structures on the first layer, and a method of manufacturing the same are provided. When the nano structure composite according to the present invention is used, a device having a field emission characteristic higher efficiency than a conventional device can be realized, and also, the device can be manufactured at a lower temperature and at a lower pressure. Thus, manufacturing cost can be reduced and a large scale process can be performed.
摘要翻译：提供了一种纳米结构复合材料及其制造方法。更具体地说，提供一种纳米结构复合体及其制造方法，其包括基板，由基板上的碳纳米结构形成的第一层和由第一层上的金属氧化物纳米结构形成的第二层。当使用根据本发明的纳米结构复合材料时，可以实现具有比常规器件更高效率的场发射特性的器件，并且还可以在较低温度和较低压力下制造器件。因此，可以降低制造成本并且可以执行大规模处理。

10. 发明申请

WO2009031802A2 NANOSTRUCTURE COMPOSITE AND METHOD OF PRODUCING THE SAME 审中-公开
标题翻译：纳米结构复合材料及其制备方法
公开(公告)号：WO2009031802A2
公开(公告)日：2009-03-12
申请号：PCT/KR2008/005165
申请日：2008-09-03
申请人： ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE , KUMOH NATIONAL INSTITUTE OF TECHNOLOGY , KIM, Sang-Hyeob , PARK, Seung-Sik , KIM, Sang-Woo , LEE, Gong-Gu , KIM, Sung-Jin , MAENG, Sunglyul , LEE, Sunyoung , MYOUNG, Hey-Jin
发明人： KIM, Sang-Hyeob , PARK, Seung-Sik , KIM, Sang-Woo , LEE, Gong-Gu , KIM, Sung-Jin , MAENG, Sunglyul , LEE, Sunyoung , MYOUNG, Hey-Jin
IPC分类号： B82B3/00
CPC分类号： H01J9/025 , H01J1/304 , H01J2201/30469 , H01J2329/0455 , Y10T428/24355
摘要： Provided is a nano structure composite and a method of manufacturing the same. More specifically, a nano structure composite that includes a substrate, a first layer formed of carbon nano structures on the substrate, and a second layer formed of metal oxide nano structures on the first layer, and a method of manufacturing the same are provided. When the nano structure composite according to the present invention is used, a device having a field emission characteristic higher efficiency than a conventional device can be realized, and also, the device can be manufactured at a lower temperature and at a lower pressure. Thus, manufacturing cost can be reduced and a large scale process can be performed.
摘要翻译：提供了纳米结构复合物及其制造方法。更具体地，提供了一种纳米结构复合物及其制造方法，该纳米结构复合物包括基底，在基底上由碳纳米结构形成的第一层和由金属氧化物纳米结构形成的第二层。当使用根据本发明的纳米结构复合材料时，可以实现具有比常规器件更高效率的场发射特性的器件，并且还可以在更低的温度和更低的压力下制造器件。因此，可以降低制造成本并且可以执行大规模的工艺。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式